Sales and Marketing

Showing 15 posts of 11528 posts found.

AZ and MSD’s Lynparza becomes first PARP inhibitor approved in US for metastatic breast cancer

January 15, 2018 Sales and Marketing AstraZeneca, Cancer, FDA, MSD, breast cancer, lynparza, pharma

The FDA has announced that it has awarded marketing authorisation in the US to Lynparza (olaparib), a poly ADP-ribose polymerase …

Universal flu vaccine receives Google’s financial backing

January 15, 2018 Sales and Marketing Vaccine, biotech, drugs, flu, pharma, pharmaceutical

Vaccitech, a spin-out company from the University of Oxford, recently launched a Series A financing round and had some fairly …

Roche’s Ocrevus gets the go ahead in Europe for two forms of MS

January 12, 2018 Medical Communications, Sales and Marketing Europe, European Commission, Ocrevus, Roche, multiple sclerosis, pharma

Roche has revealed that its multiple sclerosis (MS) drug Ocrevus (ocrelizumab) has been awarded marketing approval in Europe by the …

Novartis prises Pfizer’s Oncology Head away

January 11, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Pfizer, biotech, drugs, pharma, pharmaceutical

Novartis has been looking to find someone to fill the shoes of Bruno Strigini since it was revealed that he …

Teva execs feel the pinch, after pay halved

January 11, 2018 Medical Communications, Sales and Marketing Teva, biotech, drugs, pharma, pharmaceutical

Teva’s current crisis is built upon problems that run deep into the company, after numerous acquisitions left it bloated and …

AIDS charity lambasts “ethically challenged” Gilead over price hikes

January 11, 2018 Sales and Marketing AIDS, Gilead, HIV, Truvada, biotech, drugs, pharma, pharmaceutical

The AIDS Healthcare Foundation (AHF) has strongly criticised Gilead prices increases across the board for its HIV and AIDS treatment, …

Nestle reportedly pulls out in front to buy Merck KGaA consumer health unit with $5 billion bid

January 11, 2018 Sales and Marketing Merck KGaA, nestle, pharma

It has been reported that Swiss food giant Nestle has pulled out in front as the top bidder for Merck …

Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations

January 10, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma

Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …

Bayer and J&J successfully reverse $28 million Xarelto court payout

January 10, 2018 Research and Development, Sales and Marketing Bayer, J&J, JJ, Johnson & Johnson, Xarelto, pharma

Bayer and Johnson & Johnson have managed to avert a payout of $27.8 million after a Pennsylvania state court judge …

Shire announces split into two business units, downgrades revenue forecast

January 9, 2018 Manufacturing and Production, Sales and Marketing Shire, neuroscience, pharma, rare disease

Shire has revealed that it now plans to move forward by separating its operations into two distinct divisions: rare disease …

Ex-Genentech exec named as new Juno Therapeutics CIO

January 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, juno therapeutics

Biopharmaceutical firm and cellular immunotherapy specialist Juno Therapeutics has named Cindy Elkins as its new Chief Information Officer, where she …

Sanofi and Alynylam rejig sees global rights switch-up

January 8, 2018 Sales and Marketing Alynylam, Sanofi, biotech, drugs, pharma, pharmaceutical

The Sanofi-Alynylam alliance has been in place since 2014, with the latest development seeing the two companies each take their …

The PROs and cons of pushing patient centricity

January 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient reported outcomes, pharma

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …

FDA clears Amgen’s bone drug for multiple myeloma

January 8, 2018 Sales and Marketing Amgen, Cancer, Xgeva, multiple myeloma, pharma

Amgen has announced that the FDA has approved the indication expansion of its drug Xgeva (denosumab) to include the treatment …
The Gateway to Local Adoption Series

Latest content